ciprofloxacin has been researched along with aspartic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Deguchi, T; Fukuda, H; Ishihara, S; Kawada, Y; Yasuda, M; Yokoi, S | 1 |
| Bax, BD; Brown, KK; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Giordano, I; Gorrec, F; Gwynn, MN; Hann, MM; Hennessy, A; Hibbs, M; Huang, J; Jones, E; Jones, J; Lewis, CJ; May, EW; Pearson, ND; Saunders, MR; Shen, C; Shillings, A; Singh, O; Spitzfaden, CE; Theobald, AJ; Wohlkonig, A | 1 |
| Calderón, IL; Collao, B; Gil, F; Guerrero, P; Ipinza, F; Morales, EH; Parra, S; Saavedra, CP | 1 |
| Ramana, J | 1 |
| Gibson, H; Hussain, M; Mohammed, AR; Perrie, Y; Rahman, A; Warraich, AA | 1 |
6 other study(ies) available for ciprofloxacin and aspartic acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Topics: Anti-Infective Agents; Aspartic Acid; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Selection, Genetic; Serine | 2000 |
Type IIA topoisomerase inhibition by a new class of antibacterial agents.
Topics: Anti-Bacterial Agents; Apoenzymes; Arginine; Aspartic Acid; Binding Sites; Catalytic Domain; Ciprofloxacin; Crystallography, X-Ray; DNA; DNA Cleavage; DNA Gyrase; DNA, Superhelical; Drug Design; Drug Resistance; Escherichia coli; Manganese; Models, Molecular; Protein Conformation; Quinolines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2010 |
Characterization of the BaeSR two-component system from Salmonella Typhimurium and its role in ciprofloxacin-induced mdtA expression.
Topics: Anti-Bacterial Agents; Aspartic Acid; Ciprofloxacin; Cloning, Molecular; Gene Expression Regulation, Bacterial; Histidine; Histidine Kinase; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Protein Kinases; Salmonella typhimurium; Trans-Activators | 2012 |
Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aspartic Acid; Binding Sites; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gene Expression; Kinetics; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Norfloxacin; Protein Binding; Serine; Shigella flexneri; Thermodynamics | 2016 |
Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms.
Topics: Anti-Bacterial Agents; Aspartic Acid; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Glutamic Acid; Microbial Sensitivity Tests; Staphylococcus aureus | 2020 |